文献速递神经与头颈病理

NLRP3炎症小体作为肌萎缩侧索硬化认知韧性关键分子靶点

NLRP3 inflammasome as a key molecular target underlying cognitive resilience in amyotrophic lateral sclerosis.
PubMed 文献 · J Pathol · 2022-01-06

该研究利用13例ALS患者尸检脑组织,按生前认知状态分层比较认知受累与未受累脑区,通过NanoString 770基因panel筛选差异表达基因,并用BaseScope原位杂交和免疫组化验证,发现NLRP3炎症小体调控可能是ALS认知韧性的可治疗性病理相关因素。

要点

  • ALS患者认知受累与未受累脑区存在50个显著失调基因。
  • NLRP3炎症小体调控是认知韧性的潜在可治疗靶点。
  • 研究采用生前认知分层与尸检脑区比较的 unbiased 策略。

核心结论

  • NLRP3炎症小体调控可能是ALS认知韧性的潜在可治疗性病理相关因素。

研究设计与样本

  • 采用深度表型、临床分层的13例ALS患者三个脑区的认知受累与未受累脑区尸检组织。
  • 使用NanoString分子条形码对770基因Neuropathology Panel进行mRNA测序分析。
  • 通过BaseScope原位杂交和免疫组化进行区域和细胞类型特异性验证。

主要发现

  • 识别出50个在认知受累与未受累脑区之间显著失调且不同的基因。
  • BaseScope原位杂交显示大分子复合物调控,尤其是NLRP3炎症小体调节,与ALS认知韧性相关。

临床怎么用

  • NLRP3炎症小体可能作为ALS认知功能障碍治疗靶点和预后判断的分子指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Up to 50% of amyotrophic lateral sclerosis patients present with cognitive deficits in addition to motor dysfunction, but the molecular mechanisms underlying diverse clinical and pathological presentations remain poorly understood. There is therefore an unmet need to identify molecular drivers of cognitive dysfunction to enable better therapeutic targeting and prognostication. To address this, we employed a non-biased approach to identify molecular targets using a deeply phenotyped, clinically stratified cohort of cognitively affected and unaffected brain regions from three brain regions of 13 amyotrophic lateral sclerosis patients with the same cognitive screening test performed during life. Using NanoString molecular barcoding as a sensitive mRNA sequencing technique on post-mortem tissue, we profiled a data-driven panel of 770 genes using the Neuropathology Panel, followed by region and cell type-specific validation using BaseScope in situ hybridisation and immunohistochemistry. We identified 50 significantly dysregulated genes that are distinct between cognitively affected and unaffected brain regions. Using BaseScope in situ hybridisation, we also demonstrate that macromolecular complex regulation, notably NLRP3 inflammasome modulation, is a potential, therapeutically targetable, pathological correlate of cognitive resilience in ALS. © 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd on behalf of The Pathological Society of Great Britain and Ireland.

来源:J Pathol,查看原文。版权归原作者所有。

引用

  1. Banerjee P, Elliott E, Rifai OM, et al. NLRP3 inflammasome as a key molecular target underlying cognitive resilience in amyotrophic lateral sclerosis. J Pathol. 2022. PMID: 34883532. doi:10.1002/path.5846

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。